Microvilli length predicts clinical response to ustekinumab in Crohn's patients from the UNITI-2 trial

Kelli Van Dussen  1     Katherine Li  2     Kate Simpson  3     Brian Claggett  4     Joshua R. Friedman  2     Jacqueline Perrigoue  5     Thaddeus S. Stappenbeck    
1 University of Cincinnati College of Medicine,Cincinnati,United States
2 Janssen Research & Development,Spring House,United States
3 Washington University School of Medicine,St. Louis,United States
4 Harvard Medical School,Boston,United States
5 Janssen Research & Devel

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing